Mountain Valley MD
Developing the World’s Leading Medicinal Cannabis Ecosystem
To develop and optimize the world’s leading medicinal cannabis ecosystem.
Leveraging our core strengths in cultivation, R&D, processing, manufacturing and marketing with strategic acquisitions and partnerships, we are generating a market-leading global portfolio of leading edge, high quality, vertically-integrated, sustainable medicinal cannabis assets.
Cannabidiol - CBD
Cannabidiol or CBD, is the most abundant non-psychoactive cannabinoid found in cannabis. CBD is the leading option for those who are looking for a natural alternative to prescription or over-the-counter drugs without the mind-altering effects traditionally associated with marijuana or certain pharmaceutical drugs. Cannabidiol has been identified to relieve stiffness, chronic pain, anxiety, depression, neurological disorders, and more, and is in active evaluation for its positive impact to prevent diabetes and the spread of cancer. (healthline.com)
Across our strain genetics, cultivation, extraction and delivery sciences, MVMD prioritizes investment opportunities on disruptive technologies on the leading-edge of transforming the cannabis industry.
Mountain Valley MD is working in cannabinoid product innovation, research and development to formulate therapeutic-grade medicinal cannabis-derived nutraceutical and natural health products.
We are achieving low cost, high yield cultivation leadership out of our Colombia asset, while preserving our focus on craft-grown quality.
Key Growth Pillars
Starting with our origins in British Columbia, Canada, we concentrate on the science of high-quality craft-grown cannabis to produce some of the most premium product in the world.
Working on advance technology in Nano detection, appropriation and purification that deploys molecular imprinted polymers (MIPs) to deliver compounds with surgical precision faster and more cost effectively.
Advanced desiccated liposome science and related international patents for advanced compressible delivery formulations for transmucosal delivery for rapid, precise and cost effective delivery applications.
Our international partners are strategically sourced and invested in to enable us to access local market capabilities and expertise while creating scale across our global network.
“The global cannabis industry is in the early innings of a major growth cycle and new markets are opening all over the globe.”
“It is rare for new industries to emerge as rapidly as the cannabis sector has and even less common for Canadian enterprises to find themselves with a huge lead on foreign competition. International cannabis markets beckon Canadian LPs, who enjoy an abundance of capital and have the distinct advantage of operating in the world’s first fully legalized domestic marketplace.”
Pricewaterhouse Coopers LLP (PwC)
"Canada is poised to become the world leader in the growing cannabis industry. That potential I've never seen in my investment lifetime."
The global cannabis market:
An unprecedented opportunity...